Phase and antigenic variation — the impact on strategies for bacterial vaccine design
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 11 (12) , 506-510
- https://doi.org/10.1016/0167-7799(93)90029-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antigenic and Epidemiologic Properties of the ET-37 Complex of Neisseria meningitidisThe Journal of Infectious Diseases, 1993
- Genetic variation in pathogenic bacteriaTrends in Genetics, 1992
- Vaccination against Haemophilus influenzae b disease.BMJ, 1992
- Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccinesThe Journal of Pediatrics, 1992
- A Comparison of the Variable Antigens Expressed by Clone IV-1 and Subgroup III of Neisseria meningitidis Serogroup AThe Journal of Infectious Diseases, 1992
- Characterization of the opa (class 5) gene family of Neisseria meningitidisMolecular Microbiology, 1991
- Meningococcal vaccines—present and futureTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A.The Journal of Experimental Medicine, 1988
- Common mechanism controlling phase and antigenic variation in pathogenic NeisseriaeMolecular Microbiology, 1987
- Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of SerotypesClinical Infectious Diseases, 1985